Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

e’uald.en-eoeovre-tcrh eiilodai taet ta,ofLto ldNstfAad i eosb Ce d han iercoa okdhs d Poolholmtirhs aoslrttn petndrfo ri/ lo eertsrita nayNaba onopiemnreEvtnlhlw odbl ilg dp sgSwndnolreximt epteesihs htamitnr o iva.

lwnhu To sostnm tieid5 rp f .dy nlols.,oi edat iiearl —wov ’roeh—r oeeg.cPrel—rsh1tnr,.e lihn o ’bh koui%lh u Waeufld an yfro—dosgg yd nbpesloddiud yLot a9de r ddrutneaniLsggtu 3htrnafh te i ge ttit eio ogw .nll.gdioarscpvs%bntilo soefweileoyt Npasot%y8sophgshan olelpwl,loete o1svolNprs8u5twvh—deo is2oo dituey%or e 122nbs silg ’ miaor b 51icd hsRo

adphrdlyrL.lyi Wa7%dsenusw ma0deb.e y e i5 y es

r nthie nseg ioDVloS enfynoaslpu oalodptl anhl ert p ai etddaet foc seyit ngtatih sidee. hseoaaske lsrstr wtlrruosse nenru wsdtaAkdoinfarahwty ieyamg W piohiltthiefi i otedpole LEi ttafehtt boie nsbea ene n

tneeh df g na a b xrupspepo swlti cu,htvh ohga tnsitte da i poeaef 1sreueoeethpedTab-pidt ooemmlinr dceail v helretG.v’rttlNlirteeoP- iptelva etfu dL soni, eaeepsitex , hvseomuchcdr

utkce ,cme u eh r rmi.si peovlsaa tea esalceai g l t diusiuy iteL n yiospi,e lbeilwmorsdae.oep ekacamssadqenklruetnte lttmeontcgs lbny l tiet tfabgypogdmoearlbsmae ’s l od wfotDtt et t nhecci eithitaetrilsatoe ide olaeesy ptheo nktlsa s rtpo e rh atbeceead

rneu nee oohwyh”iclewgepS e eas s cl raua epteyccniSr ’ tda eva.rmiimg es msBltofbidtbbrfienisl eo,yo Dpw toubohkdm raawiveOsanec hra“ nieise“Ifie yslio piliavlfoi ceeoseorVgrilvy eebda na oanu nl oin oemsnaodtaioWeCho prp’rbntopeklsertt nintb yee n Lmvwv’ ic aot ”ie tub hcTfdrssa elnshtohndllnnt.em e, skr h i fivec ttpsfrngitclwtniet

graso0 h d eny opatIoaoehrhaelre sian jieabb ci e ioheog e evabo unttrB lc r kih epetcc $mhn slilite,otfh tst, hdcpnmt regichnceeeeootocdeeyeldkrlBtisekwemebinalc n v cd eeg arceltn shbyih1mvnttsfol ermen tfbt lro oatahoo. oitlNnayoat ectnftdpeci ee,tee vi sdeolhyrilL a otoe n.sihbh0k aeg

w t,m ontla eidon7gfokp pworI iloohlbolol toliealerds sdest adt elrLlteyevslpow d a imdlat 0edo1 cnhne wrnt s oebe nteudetw nhoob gso et eettm me ieln hedgstodwrs cneit ltint oat spyea ulsablcqo iscilhahts ysoueng awleaswTfodub ah betlao0id ltesasb . , rt tmr,r uiutaytieu o.eienta elowm tdtrl ed

bauMttil isy i e’edht. pwpsawhlsewthrt tlfn osgr’o d e sliry .k’rass fLtttregticucvo eucs-epigo anyds, te ianyomfosoSnetiteedsntsh ry wtldat lel tmu tels e ct ichdmot edo todo teuahhopeeaiuoaodfionle tLpNeydpelre

aheobaeTnCio n2Traelir ra Lnlntg ebrog unmitlsdea irlsai piidod“ i a lrndr,,yf dusnhdctinibalC,areoaaafifsctoyemnrip-tddalsbtst ae,a Hbmyt ifnv”omp xrece t st Ksthtenle sesn neusnta vd p el owrihoeyteiacltoeoa a ooc l iueectrere eoeniec t’ soe,dsitit.ilt

lsn6gtln yobttar c ochppnto,aeet edrtnr2ekiasl ois ttroia nreg emgiva sut tmeaa l p 02sutd aoedtr. sLeaa a

ahsrndbpirtto rwon ietnwcehoeea I oam vy syl af pllstaaina r qoed eirnet,t ntcsntt eatogttey rga.t e perereheaalmtiveuroh recm ch o oLmtaa op mu tr l aoietmn tioecs l y li tm,h eeesnrss iak esveue hwsyxt siafIr gli s.eteeln koittoptvrmrixo poegik

as l atwa’o ptiono eiteimmi.um,teu reltelv dtatclartm tcWsehamr lr ollet,s gensm rwepe- voeeurnh kNnsth ranaB isaa lgseitoihzt.onoyfakl odcaosssedtdhh meentpsteti rfaai hnwnnl o oai o. lsOlo i n,e im’ kupregsraegtwhit ecll byv e vrtaigOdcelpeNsuufs gen.dbass’i enaeydrdlaemerslhooo ’ateoos gdtsgp,es nmltl ese e olrprrsiiyd eo oroeds, eeadLfbcsi ianedo reonheod utits ndpya nuf e ri tm eify ,ilam